Clinical trial
Antimicrobial Resistance in Cystic Fibrosis (CF)
NCT00360503 · Seattle Children's Hospital, Other · Completed
Key facts
| NCT number | NCT00360503 |
|---|---|
| Title | Antimicrobial Resistance in Cystic Fibrosis (CF) |
| Official title | Antimicrobial Resistance in Sputum Obtained From Patients With Cystic Fibrosis (CF) |
| Lead sponsor | Seattle Children's Hospital, Other |
| Collaborators | Cystic Fibrosis Foundation |
| Status | Completed |
| Study type | Observational |
| Conditions | Cystic Fibrosis |
| Enrollment | 304 |
| Start date | Mar 1, 2006 |
| Completion | Jun 1, 2008 |
| First posted | Aug 4, 2006 |
| Last update posted | Feb 10, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: